BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $974,000 | +181.5% | 15,159 | +252.9% | 0.01% | +200.0% |
| Q2 2021 | $346,000 | -4.4% | 4,296 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $362,000 | +67.6% | 4,296 | +71.3% | 0.00% | +33.3% |
| Q2 2020 | $216,000 | -80.6% | 2,508 | -81.7% | 0.00% | -82.4% |
| Q1 2020 | $1,112,000 | -19.9% | 13,690 | -17.6% | 0.02% | +54.5% |
| Q4 2019 | $1,389,000 | -8.1% | 16,605 | -3.9% | 0.01% | -8.3% |
| Q3 2019 | $1,512,000 | -25.0% | 17,277 | -29.8% | 0.01% | -20.0% |
| Q2 2019 | $2,015,000 | -10.2% | 24,601 | -10.9% | 0.02% | -6.2% |
| Q1 2019 | $2,245,000 | +261.5% | 27,612 | +169.1% | 0.02% | +300.0% |
| Q2 2017 | $621,000 | +17.4% | 10,261 | +0.5% | 0.00% | 0.0% |
| Q1 2017 | $529,000 | +12.6% | 10,209 | -3.7% | 0.00% | +33.3% |
| Q4 2016 | $470,000 | -98.6% | 10,602 | -98.5% | 0.00% | -98.9% |
| Q3 2016 | $33,101,000 | +63.4% | 695,392 | +31.0% | 0.27% | +36.4% |
| Q4 2015 | $20,255,000 | -88.9% | 530,929 | -4.5% | 0.20% | +3.1% |
| Q3 2015 | $182,559,000 | +612.8% | 555,734 | +51.7% | 0.19% | -12.3% |
| Q2 2015 | $25,613,000 | +6.8% | 366,260 | +4.6% | 0.22% | +11.7% |
| Q1 2015 | $23,990,000 | +12.7% | 350,225 | +20.6% | 0.20% | +17.4% |
| Q4 2014 | $21,281,000 | +29.6% | 290,368 | +26.9% | 0.17% | +30.5% |
| Q3 2014 | $16,421,000 | +14.0% | 228,798 | +14.9% | 0.13% | +3.2% |
| Q2 2014 | $14,401,000 | +17.5% | 199,182 | +19.6% | 0.12% | +3.3% |
| Q1 2014 | $12,253,000 | +19.8% | 166,531 | +11.2% | 0.12% | +15.4% |
| Q4 2013 | $10,232,000 | – | 149,805 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |